Prostate Cancer
Conditions
Keywords
Prostate Cancer, Novel hormonal therapy, Androgen-deprivation therapy
Brief summary
The purpose of this study is to quantify the preferences for novel hormonal therapy (NHT) +/- androgen-deprivation therapy (ADT) vs ADT monotherapy among patients with non-metastatic hormone-sensitive prostate cancer (PC) in the United States (US), Germany, Spain, France, Italy, the United Kingdom (UK), South Korea, Australia, and Brazil, using a discrete choice experiment (DCE).
Detailed description
The study will collect data from eligible patients (six total) and physicians (six total) from one-on-one qualitative interviews and eligible patients from online surveys. Approximately 330 patients with PC will be recruited to complete the online DCE survey.
Interventions
OTHERNo Intervention
No investigational drug will be administered to participants in this study.
Sponsors
Astellas Pharma Global Development, Inc.
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Physician inclusion criteria * The physician is a certified urologist or oncologist. The final selection will be adjusted to local practice. * The physician has cared for at least ten nmHSPC patients in the past year. * The physician has experience prescribing NHT and ADT. Patient inclusion criteria * The patient has nmHSPC after radiotheraphy (RT) and/or radical prostatectomy (RP), defined as an adult patient with nmPC who had RT and/or RP.
Exclusion criteria
Physician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patients' Preference weights for different treatment attributes | Up to 1 day | Preference data will be collected via online survey questionnaires designed using DCE method. |
| Patients' Overall Preference for a specific treatment profile (NHT +/- ADT or ADT monotherapy) | Up to 1 day | Preference data will be collected via online survey questionnaires designed using DCE method. |
Countries
United States
Outcome results
None listed